Cullinan Therapeutics (CGEM) Change in Account Payables (2020 - 2023)
Historic Change in Account Payables for Cullinan Therapeutics (CGEM) over the last 4 years, with Q4 2023 value amounting to $1.5 million.
- Cullinan Therapeutics' Change in Account Payables rose 3467.25% to $1.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$167000.0, marking a year-over-year increase of 6719.06%. This contributed to the annual value of -$812000.0 for FY2024, which is 38622.75% down from last year.
- Latest data reveals that Cullinan Therapeutics reported Change in Account Payables of $1.5 million as of Q4 2023, which was up 3467.25% from -$1.5 million recorded in Q3 2023.
- In the past 5 years, Cullinan Therapeutics' Change in Account Payables ranged from a high of $4.5 million in Q4 2020 and a low of -$4.1 million during Q1 2021
- For the 4-year period, Cullinan Therapeutics' Change in Account Payables averaged around $4375.0, with its median value being $315500.0 (2020).
- Per our database at Business Quant, Cullinan Therapeutics' Change in Account Payables tumbled by 252588.24% in 2021 and then soared by 17606.69% in 2022.
- Over the past 4 years, Cullinan Therapeutics' Change in Account Payables (Quarter) stood at $4.5 million in 2020, then tumbled by 74.65% to $1.1 million in 2021, then changed by 0.0% to $1.1 million in 2022, then skyrocketed by 34.67% to $1.5 million in 2023.
- Its Change in Account Payables stands at $1.5 million for Q4 2023, versus -$1.5 million for Q3 2023 and $461000.0 for Q2 2023.